Trial Profile
A phase I trial of carboplatin and Abraxane [paclitaxel] in patients with solid tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 06 Feb 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual end date (1 Sep 2007 ) added as reported by ClinicalTrials.gov.